Right Heart Bypass (Cavopulmonary Anastomosis)

Subscribe to Selected New Research on Right Heart Bypass

224 relevant articles (9 outcomes, 4 trials/studies) found for this Therapy

Description: Diversion of the flow of blood from the entrance to the right atrium directly to the pulmonary arteries, avoiding the right atrium and right ventricle (Dorland, 28th ed). This a permanent procedure often performed to bypass a congenitally deformed right atrium or right ventricle.

Also Known As:

Cavopulmonary Anastomosis; Heart Bypass, Right; Anastomosis, Cavopulmonary; Cavopulmonary Shunt; Shunt, Cavopulmonary; Anastomoses, Cavopulmonary; Bypasses, Right Heart; Cavopulmonary Anastomoses; Cavopulmonary Shunts; Heart Bypasses, Right; Right Heart Bypasses; Shunts, Cavopulmonary; Bypass, Right Heart

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 4

Surgical Anastomosis: 83

Right Heart Bypass: 224

Fontan Procedure: 659

Thoracic Surgical Procedures: 43

Cardiac Surgical Procedures: 203

Right Heart Bypass: 224

Fontan Procedure: 659

Cardiovascular Surgical Procedures: 18

Cardiac Surgical Procedures: 203

Right Heart Bypass: 224

Fontan Procedure: 659

Experts

1.	Duncan, Brian W: 3 articles (08/2008 - 11/2002)
2.	Tanoue, Yoshihisa: 2 articles (11/2004 - 01/2002)
3.	Karl, T R: 2 articles (01/2001 - 03/2000)
4.	Tipps, Russell S: 1 article (08/2008)
5.	Leahy, Patrick: 1 article (08/2008)
6.	Mumtaz, Muhammed: 1 article (08/2008)
7.	Kagawa, Kiyokazu: 1 article (04/2008)
8.	Kinouchi, Keiko: 1 article (04/2008)
9.	Hanamoto, Hiroshi: 1 article (04/2008)
10.	Tachibana, Kazuya: 1 article (04/2008)

Related Diseases

1.	Heart Diseases (Heart Disease) 08/01/1990 - "Total cavopulmonary shunt can produce a marked improvement in the condition of patients with some type of complex cyanotic congenital heart disease." 10/01/1994 - "Bidirectional cavopulmonary anastomosis (BCA) is thought to be beneficial in the palliation of patients with univentricular congenital heart disease considered at high risk for Fontan repair" 01/01/2005 - "Fontan right heart bypass as a corrective procedure for congenital heart disease with single-ventricle hemodynamics]" 10/06/2004 - "BACKGROUND: The surgical superior cavopulmonary anastomosis is performed as part of the staged Fontan pathway to treat univentricular forms of congenital heart disease; PAVS is a known sequela after superior cavopulmonary anastomosis and may have important clinical consequences" 01/01/2004 - "During cardiac catheterization, 19 patients with complex cyanotic heart disease who had undergone a cavopulmonary shunt or Fontan procedure were studied" Order ALL the reference details at left...
2.	Cyanosis 02/01/2008 - "Conversion from total cavopulmonary shunt to Fontan circulation: improved cyanosis with an 11-year interval." 08/01/2004 - "Stage II surgery, or partial cavopulmonary anastomosis, relieves both parallel circulation and volume overload, but not cyanosis" 12/01/2003 - "Cyanosis and the cavopulmonary anastomosis (CPA) are associated with pulmonary arterio-venous malformations (PAVMs) in single ventricle physiology" 08/01/1999 - "We describe a 6 month old boy with a complex imbalanced atrioventricular septal defect who developed cyanosis in the very early postoperative period, following bidirectional cavopulmonary anastomosis" 01/01/1996 - "Of 320 children with cyanotic congenital heart malformations who had previously undergone cavopulmonary shunt operations, 11 had increasing cyanosis and exercise intolerance and were considered unsuitable for definitive repair, a Fontan procedure, or other palliation" Order ALL the reference details at left...
3.	Syndrome 02/01/1990 - "The right heart bypass operation, like total cavopulmonary shunt or connection, simplifies the redirection of systemic venous drainage and offers improved results in the surgical treatment of complex cardiovascular anomalies with viscero-atrial heterotaxic syndrome." 11/01/2005 - "Right heart bypass for acute traumatic respiratory distress syndrome." 06/01/1997 - "CONCLUSIONS: Bidirectional cavopulmonary shunt can be performed in patients with anomalous systemic or pulmonary venous drainage, including those with visceral heterotaxy syndrome, with morbidity and mortality rates that do not differ significantly from those achieved in all patients undergoing bidirectional cavopulmonary shunt" 06/01/1997 - "Among all patients undergoing bidirectional cavopulmonary shunt during this time period, neither heterotaxy syndrome nor anomalies of systemic or pulmonary venous return were significantly associated with decreased survival or poor outcome" 01/01/1995 - "Pulsatile total cavopulmonary shunt for hypoplastic right heart syndrome with abnormal systemic venous return--a case report]" Order ALL the reference details at left...
4.	Patent Ductus Arteriosus 08/01/1985 - "A 22-month-old male infant with single atrium, single ventricle, regurgitant common atrioventricular valve, pulmonary atresia, patent ductus arteriosus, and inferior vena cava defect with azygos connection was treated successfully with total cavopulmonary shunt and replacement of the common atrioventricular valve" 11/01/1991 - "These residua included stenosis of the cavopulmonary anastomosis (1 patient), unsatisfactory atrial fenestration (2 patients), patent ductus arteriosus (1 patient), residual cavoatrial shunting (1 patient), atrial thrombi (1 patient), and poor ventricular function (2 patients)" Order ALL the reference details at left...
5.	Neoplasms (Cancer) 11/01/2000 - "Remission of the tumor after chemotherapy allowed subsequent takedown of the cavopulmonary anastomosis." 11/01/2000 - "Partial debulking of the tumor along the left pulmonary artery and creation of a cavopulmonary anastomosis on the right pulmonary artery restored satisfactory perfusion of the lungs and unloading of the right ventricle in a 19-year-old woman" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Oxygen
2.	Lactic Acid
3.	stroma free hemoglobin
4.	N-(3,4,5-trichlorophenyl)succinimide
5.	crystalloid solutions
6.	Dexmedetomidine
7.	Brain Natriuretic Peptide (Natrecor)
8.	15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
9.	Urethane (Ethyl Carbamate)
10.	Superoxide Dismutase

Related Therapies and Procedures

1.	Right Heart Bypass (Cavopulmonary Anastomosis)
2.	Drug Therapy (Chemotherapy)
3.	Stents
4.	Fontan Procedure (Fontan Operation)
5.	Transplants (Transplant)

Best Treatments:
Research Summary Report
on Heart Diseases

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 480 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>